GO-8: Gene Therapy for Haemophilia A Using a Novel Serotype 8 Capsid Pseudotyped Adeno-associated Viral Vector Encoding Factor VIII-V3

Study Summary

The GO-8 study focuses on assessing safety and efficacy of gene therapy for patients with severe haemophilia A

Interventions

Study Locations

Facility	City	State	Country
St. Luke'S Regional Medical Center, Ltd	Boise	Idaho	United States
University of Kentucky	Lexington	Kentucky	United States
St Jude's Children's Research Hospital	Memphis	Tennessee	United States
Royal Free Hospital	London		United Kingdom

Official Trial Information

View on ClinicalTrials.gov